---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-006335"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:12:41.245035+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bioventus deconsolidates CartiHeal after settlement, records $88.5M loss on disposal

## Summary
- Transferred CartiHeal shares to trustee and paid $10M to former securityholders under settlement agreement.
- Deconsolidation effective Feb 27, 2023; CartiHeal treated as discontinued operation with $88.5M loss on disposal.
- Pro forma net loss for nine months ended Oct 1, 2022 increases to $134.3M from $126.8M historical.
- Settlement resolves non-payment of $50M milestone triggered Feb 13, 2023; company avoids litigation.
- Bioventus retains no ownership or voting rights in CartiHeal during interim period.

## SEC filing metadata
- accession: 0001628280-23-006335
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/0001628280-23-006335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/bvs-20230227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-006335
- JSON: https://secwatch.observer/filing/0001628280-23-006335.json
- Plain text: https://secwatch.observer/filing/0001628280-23-006335.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.